Search

Your search keyword '"cell- and tissue-based therapy"' showing total 91 results

Search Constraints

Start Over You searched for: Descriptor "cell- and tissue-based therapy" Remove constraint Descriptor: "cell- and tissue-based therapy" Language japanese Remove constraint Language: japanese
91 results on '"cell- and tissue-based therapy"'

Search Results

1. [Hyperthermia Enhances Antitumor Effects of Immune Checkpoint Inhibitors and Immune Cell Therapy].

2. [Current Trend of CAR-T Cell Therapy for Metastatic Castration-Resistant Prostate Cancer].

Catalog

Books, media, physical & digital resources

3. [Japan or Global Development Trends in Cell Therapy].

4. [Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].

5. [Management of adverse events of CAR-T therapy].

6. [Current and future perspectives on CAR-T cell therapy to adult malignant lymphoma].

8. [Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy].

9. [Development of next-generation chimeric antigen receptor-engineered T-cell therapy].

10. [Cell therapy using amnion-derived mesenchymal stem cells].

11. [Development of CAR-T cell therapy using allogeneic iPS cells].

12. [Coagulopathy related to CAR-T cell therapy].

13. [Clinical development of chimeric antigen receptor T-cell therapy in multiple myeloma].

14. [Clinical experience of leukapheresis for CD19 CAR-T cell therapy].

15. [Chimeric antigen receptor T-cell therapy for multiple myeloma].

17. [Neurotoxicities Associated with CAR-T Cell Therapy].

18. [Cell Therapy Using Peripheral Mononuclear Cells Preconditioned by Oxygen-Glucose Deprivation for Ischemic Stroke].

19. [Reconstitution of the hematopoietic system and clinical applications of iPS cells].

20. [Effects of Immune Checkpoint Inhibitor Combined with Dendritic Cell Therapy and Hyperthermia].

21. [Recent Advances in Immunotherapy for Non-Small Cell Lung Cancer].

22. [Chimeric antigen receptor T-cell therapy for multiple myeloma].

23. [Current status of the regulation and development of cell therapy products in Japan].

24. [iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas].

25. [Immune cell therapy using iPS cells].

26. [Chimeric antigen receptor T cell (CAR-T) therapy for refractory/relapsed hematological malignancy].

27. [Current status of development for regenerative cell therapy, SB623].

29. New development of diagnosis and treatment for Parkinson's disease.

30. [Present and Future of an iPS Cell Stock for Regenerative Medicine].

31. Gene-modified T cell therapy.

32. Chimeric antigen receptor (CAR)-T cell therapy.

33. Dendritic cell vaccines loaded with autologous tumor lysates for solid tumors.

34. Cell-based therapies for Parkinson's disease.

35. New Treatments for Stargardt Disease and Related Retinal Degenerative Diseases.

36. [Human mesenchymal stromal/stem cell as a source of cell therapy and a pharmacological target for disease treatment.]

37. [Untitled]

39. [Possibility of regenerative medicine on diabetic neuropathy].

40. [Cell-based therapy].

41. [Retinal Cell Therapy Using iPS Cells].

42. [Application for Lifestyle disease by iPS cells technologies].

43. Historical perspectives and future directions of gene-modified T-cell therapy.

44. [Regenerative medicine for cartilage defect in rheumatic disease].

46. [Immunotherapy for head and neck cancer].

50. [Blood cell generation from iPS cells].